234 results on '"Servant, N."'
Search Results
2. Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
3. Rectification d’un diagnostic initial d’insensibilité complète aux androgènes : complémentarité de l’examen clinique et de l’analyse génétique
4. Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: Experience of the REMAGUS 02 phase II trial
5. Conséquence de la perte fonctionnelle de la lysine déméthylase KDM1A sur la méthylation des histones, la conformation chromatinienne et expression génique dans l’hyperplasie macronodulaire bilatérale des surrénales GIP-dépendante
6. Deciphering High-Resolution 3D Chromatin Organization via Capture Hi-C
7. Aménorrhées XY de l’adolescente
8. 75P Tumor mutational burden in clinical routine practice: Identifying the right threshold?
9. 2406P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial
10. 923P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic head & neck squamous cell carcinoma – subgroup analysis of the PEVOsq basket trial
11. 864P Serial cell-free tumor DNA in prognosing survival in patients with head and neck squamous cell carcinoma treated with upfront surgery
12. ACTuDB, a new database for the integrated analysis of array-CGH and clinical data for tumors
13. A Conserved Noncoding Locus Regulates Random Monoallelic Xist Expression across a Topological Boundary
14. Amifostine and Dexrazoxane Enhance the Rapid Loss of Bone Mass and Further Deterioration of Vertebrae Architecture in Female Rats
15. Gender-Dependent Reductions in Vertebrae Length, Bone Mineral Density and Content by Doxorubicin Are Not Reduced by Dexrazoxane in Young Rats: Effect on Growth Plate and Intervertebral Discs
16. Isolated ‘idiopathic’ micropenis: hidden genetic defects?
17. Un nouveau variant en 5′UTR du gène du récepteur des androgènes (RA) chez deux patientes porteuses d’insensibilité complète aux androgens (ICA) avec séquence codante normale
18. Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets
19. Family history is under-estimated in children with isolated hypospadias: a French multicenter report of 88 families
20. Testotoxicosis without Testicular Mass: Revealed by Peripheral Precocious Puberty and Confirmed by Somatic LHCGR Gene Mutation
21. EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells
22. Testotoxicosis without Testicular Mass: Revealed by Peripheral Precocious Puberty and Confirmed by Somatic LHCGR Gene Mutation.
23. PO-497 Microtubule regulatory proteins as predictive biomarkers of taxane-based chemoresistance in breast cancer?
24. Genetic and epigenetic features direct differential efficiency of Xist-mediated silencing at X-chromosomal and autosomal locations
25. Retrospective analysis of a SHIVA01 trial cohort using functional mutational analysis successfully predicted treatment outcome
26. Effective normalization for copy number variation in Hi-C data
27. Functional mutational analysis to assess the oncogenic activity of variant of uncertain significance (VUS) detected in patients included in the SHIVA trial
28. LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation
29. RNAi-dependent and independent control of LINE1 accumulation and mobility in mouse embryonic stem cells
30. Proffered Paper: Mechanical induction of the tumourogenic beta-catenin pathway by tumour growth pressure
31. 1268P - Retrospective analysis of a SHIVA01 trial cohort using functional mutational analysis successfully predicted treatment outcome
32. Integrating a Molecular Signature of Intrinsic Radiosensitivity Into the Classification of Breast Cancer
33. De Novo Mutation Detection from Ctdna Correlates with Variants Detected on Metastasis of Patients with Any Kind of Refractory Cancer from the Shiva Trial
34. Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
35. 11LBA - Functional mutational analysis to assess the oncogenic activity of variant of uncertain significance (VUS) detected in patients included in the SHIVA trial
36. Abstract P2-11-11: Clinical utility of a radiosensitivity molecular signature: Identification of breast cancer patients that benefit from RT boost dose
37. SP002 Bioinformatics analysis for real-time applications
38. Poster session 7. Clinical Studies - non-phase 1
39. Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Refractory Cancer Patients: Shiva Design
40. A Prospective Randomized Trial Evaluating Gene Expression Arrays to Select Neoadjuvant Chemotherapy Regimen for Operable Breast Cancer: First Report of the Remagus04 Trial
41. 114 Validation process of a gene-expression signature of local recurrences after breast-conserving treatments
42. Tumour Aromatase Expression, a Prognostic for Local Control in Young Breast Cancer Patients after Breast-Conserving Treatment?
43. Do Transcriptomic Markers Provide Significant and Stable Information in Addition to Standard Markers, for the Prediction of Pathological Complete Response in Breast Cancer?
44. A molecular tool to distinguish breast carcinoma metastases to the ovary and primary ovarian carcinomas
45. Egr-1 negatively regulates expression of the sodium?calcium exchanger-1 in cardiomyocytes in vitro and in vivo
46. Gender-Dependent Reductions in Vertebrae Length, Bone Mineral Density and Content by Doxorubicin Are Not Reduced by Dexrazoxane in Young Rats: Effect on Growth Plate and Intervertebral Discs
47. A new mutation of the androgen receptor, P817A, causing partial androgen insensitivity syndrome: in vitro and structural analysis
48. 1571PD - De Novo Mutation Detection from Ctdna Correlates with Variants Detected on Metastasis of Patients with Any Kind of Refractory Cancer from the Shiva Trial
49. Androgen insensitivity syndrome,Syndromes d'insensibilité aux androgènes
50. Mechanical induction of the oncogenic Beta-catenin pathway by tumour growth pressure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.